Korean Society of Thoracic Radiology Guideline for Lung Cancer Screening with Low-Dose CT

Lee, Hyun Ju; Kim, Jin Hwan; Kim, Yoon Kyung; Park, Chang Min; Yi, Chin A; Jeong, Yeon Joo

doi:10.3348/jksr.2012.67.5.349

Cited by 9 publications

(7 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…47 Accordingly, Korea has developed guidelines for the screening of lung cancer among heavy smokers, aged 50 to 74 years, which includes guidance on the evaluation of nodules detected during screening. 15 Several populations in Asia, especially Chinese and Korean men, have higher lung cancer incidence rates than those noted in Asian subjects residing in Western countries such as the United States. 44 This finding may reflect both higher smoking rates and the presence of other risk factors.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Evaluation of Pulmonary Nodules

Bai

Choi

Chu

et al. 2016

Chest

158

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

“…1 Systematic radiography screening has been common in many Asian countries (eg, for TB and malignancy) and has led to a large number of incidental pulmonary nodules being detected. 15 1.1. In an individual with an indeterminate nodule that is visible on chest radiography, review prior imaging tests.…”

Section: Recommendationsmentioning

confidence: 99%

Evaluation of Pulmonary Nodules

Bai

Choi

Chu

et al. 2016

Chest

158

View full text Add to dashboard Cite

show abstract

“…There may or may not be clinical guidelines on the management of pulmonary nodules in Asian countries and where guidelines are provided, they vary widely. There are national society guidelines in Japan (8), Korea (9) and China, and in other countries healthcare practitioners optionally refer to individual institutional standards or to western guidelines. To provide common guidelines for practitioners throughout Asia, consensus-based expert recommendations were used to produce a set of consensus guidelines by adapting the guidelines of the American College of Chest Physicians (CHEST) (1).…”

Section: Challenges Of Guidelinesmentioning

confidence: 99%

“…The current guidelines for GGN management mainly focus on the size, solidity, and growth rate of the nodules (1,8,9). However, the location of the nodules, which is less mentioned in the guidelines, is critical in decision making in real clinical practice.…”

Section: Location Of Ggns: What Really Mattersmentioning

confidence: 99%

Managing screening-detected subsolid nodules—the Asian perspective

Sato¹,

Yang²,

Tian³

et al. 2021

Transl Lung Cancer Res

View full text Add to dashboard Cite

The broad application of low-dose computed tomography (CT) screening has resulted in the detection of many small pulmonary nodules. In Asia, a large number of these detected nodules with a radiological ground glass pattern are reported as lung adenocarcinomas or premalignant lesions, especially among female non-smokers. In this review article, we discuss controversial issues and conditions involving these subsolid pulmonary nodules that we often face in Asia, including a lack or insufficiency of current guidelines; the roles of preoperative biopsy and imaging; the location of lesions; appropriate selection of localization techniques; the roles of dissection and sampling of frozen sections and lymph nodes; multifocal lesions; and the roles of non-surgical treatment modalities. For these complex issues, we have tried to present up-to-date evidence and our own opinions regarding the management of subsolid nodules. It is our hope that this article helps surgeons and physicians to manage the complex issues involving ground glass nodules (GGNs) in a balanced manner in their daily practice and provokes further discussion towards better guidelines and/or algorithms.

show abstract

“…Korean Society of Thoracic Radiology Guideline for Lung Cancer Screening with Low-Dose CT 21 1. guideline for the use of screening with low-dose CT for lung cancer…”

Section: Lee Hj 2012mentioning

confidence: 99%

Analysis of Existing Guidelines and Randomized, Controlled, Clinical Trials for Development of [Guideline of Clinical Trial with Herbal Medicinal Product for Lung Cancer]

et al. 2019

View full text Add to dashboard Cite

Objectives: This study aimed to ascertain what should be considered in the "Guideline for Clinical Trials with Herbal Medicinal Products for Lung Cancer" by analyzing the existing guidelines and clinical trials. Methods: The committee searched guidelines and clinical trials about herbal medicine for lung cancer. The searched trials were analyzed in terms of inclusion and exclusion of participants, intervention, comparator, outcomes and trial design. Then, we compared the results of our analysis with the guidelines to identify the issues we will have to consider when making the "Guideline for Clinical Trials with Herbal Medicinal Products for Lung Cancer". Several guidelines for anti-tumor agents and clinical trials with herbal medicine were searched on the national institution homepage. The search terms were as follows: 'lung neoplasm', 'herbal medicine', 'Medicine, Korean traditional', 'Medicine, Chinese Traditional' etc. Results: There was no guideline for clinical trial with herbal medicine for lung cancer. In addition, 7 articles were searched through database searching. All the participants had non-small cell lung cancer. The type of intervention was decoction. Comparators included conventional treatments such as chemotherapy. The outcome measurements used in the studies were quality of life, tumor response, and survival duration, etc. Safety was evaluated by recording adverse events and blood test. Conclusions: Findings were made by reviewing existing guidelines and comparing them with clinical trials for lung cancer and herbal medicinal products. These results will be utilized in the development of "Guideline for Clinical Trials with Herbal Medicinal Products for Lung Cancer".

show abstract

Korean Society of Thoracic Radiology Guideline for Lung Cancer Screening with Low-Dose CT

Cited by 9 publications

References 23 publications

Evaluation of Pulmonary Nodules

Evaluation of Pulmonary Nodules

Managing screening-detected subsolid nodules—the Asian perspective

Analysis of Existing Guidelines and Randomized, Controlled, Clinical Trials for Development of [Guideline of Clinical Trial with Herbal Medicinal Product for Lung Cancer]

Contact Info

Product

Resources

About